UK MPs urge wider NHS access to weight-loss jabs, call current rollout unambitious

UK MPs have criticized the government's plan to provide Mounjaro to only 6% of eligible patients by 2028 as unambitious, urging broader NHS access. The policy debate centers on cost-effectiveness and public health impact, with uncertainty over funding and supply. This signals potential expansion of obesity treatment coverage, affecting healthcare budgets and pharmaceutical demand.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works